•
Mar 31, 2023

BellRing Q2 2023 Earnings Report

BellRing reported a strong second quarter performance, exceeding expectations with robust consumption growth in Premier Protein and Dymatize, and raised its fiscal year 2023 outlook.

Key Takeaways

BellRing Brands reported a strong second quarter with net sales of $385.6 million, a 22.3% increase year-over-year. Operating profit reached $58.0 million, and net earnings available to common stockholders were $30.9 million. The company raised its fiscal year 2023 net sales guidance to $1.61-$1.66 billion and Adjusted EBITDA guidance to $320-$335 million.

Net sales increased by 22.3% to $385.6 million, driven by price/mix and volume improvements.

Operating profit grew by 74.7% to $58.0 million.

Premier Protein and Dymatize experienced robust consumption growth and gained market share.

Fiscal year 2023 net sales guidance raised to $1.61-$1.66 billion and Adjusted EBITDA guidance to $320-$335 million.

Total Revenue
$386M
Previous year: $315M
+22.3%
EPS
$0.24
Previous year: $0.23
+4.3%
Premier Protein Volume Growth
4.5%
Gross Profit
$117M
Previous year: $87M
+34.6%
Cash and Equivalents
$25.5M
Previous year: $69.5M
-63.3%
Total Assets
$773M
Previous year: $658M
+17.5%

BellRing

BellRing

Forward Guidance

BellRing management has raised its guidance range for net sales to $1.61-$1.66 billion from $1.56-$1.64 billion and Adjusted EBITDA to $320-$335 million from $306-$325 million (resulting in net sales and Adjusted EBITDA growth of 17%-21% and 18%-23%, respectively, over fiscal year 2022). BellRing management now expects fiscal year 2023 capital expenditures of approximately $6 million.

Positive Outlook

  • Net sales guidance raised to $1.61-$1.66 billion.
  • Adjusted EBITDA guidance raised to $320-$335 million.
  • Net sales growth of 17%-21% over fiscal year 2022 expected.
  • Adjusted EBITDA growth of 18%-23% over fiscal year 2022 expected.
  • Fiscal year 2023 capital expenditures expected to be approximately $6 million.